Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Saved in:

Bibliographic Details
Main Authors:	Wirongrong Chierakul, Siriluck Anunnatsiri, Wipada Chaowagul, Sharon J. Peacock, Ploenchan Chetchotisakd, Nicholas P. Day
Other Authors:	Mahidol University
Format:	Letter
Published:	2018
Subjects:	Medicine
Online Access:	https://repository.li.mahidol.ac.th/handle/123456789/24784
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Mahidol University

id	th-mahidol.24784
record_format	dspace
spelling	th-mahidol.247842018-08-24T09:02:19Z Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4] Wirongrong Chierakul Siriluck Anunnatsiri Wipada Chaowagul Sharon J. Peacock Ploenchan Chetchotisakd Nicholas P. Day Mahidol University Khon Kaen University Sappasitthiprasong Hospital Nuffield Department of Clinical Medicine Medicine 2018-08-24T02:02:19Z 2018-08-24T02:02:19Z 2007-08-15 Letter Clinical Infectious Diseases. Vol.45, No.4 (2007), 521-523 10.1086/520011 10584838 2-s2.0-34547647816 https://repository.li.mahidol.ac.th/handle/123456789/24784 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34547647816&origin=inward
institution	Mahidol University
building	Mahidol University Library
continent	Asia
country	Thailand Thailand
content_provider	Mahidol University Library
collection	Mahidol University Institutional Repository
topic	Medicine
spellingShingle	Medicine Wirongrong Chierakul Siriluck Anunnatsiri Wipada Chaowagul Sharon J. Peacock Ploenchan Chetchotisakd Nicholas P. Day Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
author2	Mahidol University
author_facet	Mahidol University Wirongrong Chierakul Siriluck Anunnatsiri Wipada Chaowagul Sharon J. Peacock Ploenchan Chetchotisakd Nicholas P. Day
format	Letter
author	Wirongrong Chierakul Siriluck Anunnatsiri Wipada Chaowagul Sharon J. Peacock Ploenchan Chetchotisakd Nicholas P. Day
author_sort	Wirongrong Chierakul
title	Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
title_short	Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
title_full	Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
title_fullStr	Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
title_full_unstemmed	Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
title_sort	addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]
publishDate	2018
url	https://repository.li.mahidol.ac.th/handle/123456789/24784
_version_	1763491920286318592

Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Similar Items